Skip to results
Modify your search
NARROW
1-11 of 11
Authors: Kei Muro
Sort by
Journal Article
Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study
Yukiya Narita and others
The Oncologist, oyae328, https://doi.org/10.1093/oncolo/oyae328
Published: 02 December 2024
Journal Article
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study
Akinobu Nakata and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae223, https://doi.org/10.1093/oncolo/oyae223
Published: 11 September 2024
Journal Article
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G)
Yosuke Kito and others
The Oncologist, Volume 29, Issue 3, March 2024, Pages e330–e336, https://doi.org/10.1093/oncolo/oyad296
Published: 10 November 2023
Journal Article
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study
Hiroya Taniguchi and others
The Oncologist, Volume 28, Issue 11, November 2023, Pages e1108–e1113, https://doi.org/10.1093/oncolo/oyad143
Published: 07 June 2023
Journal Article
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V. Catenacci and others
The Oncologist, Volume 26, Issue 10, October 2021, Pages e1704–e1729, https://doi.org/10.1002/onco.13907
Published: 03 September 2021
Journal Article
Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT)
Sun Young Kim and others
The Oncologist, Volume 26, Issue 6, June 2021, Pages e954–e962, https://doi.org/10.1002/onco.13735
Published: 23 March 2021
Journal Article
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer
Stefano Cascinu and others
The Oncologist, Volume 26, Issue 3, March 2021, Pages e414–e424, https://doi.org/10.1002/onco.13623
Published: 23 December 2020
Journal Article
Phase I Study of Alternate‐Day Administration of S‐1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer
Toshiki Masuishi and others
The Oncologist, Volume 25, Issue 11, November 2020, Pages e1614–e1620, https://doi.org/10.1634/theoncologist.2020-0463
Published: 17 June 2020
Journal Article
Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real‐World Clinical Setting
Kensei Yamaguchi and others
The Oncologist, Volume 24, Issue 7, July 2019, Pages e450–e457, https://doi.org/10.1634/theoncologist.2018-0377
Published: 03 January 2019
Journal Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer
Yoshihiko Fujita and others
The Oncologist, Volume 24, Issue 3, March 2019, Pages 327–337, https://doi.org/10.1634/theoncologist.2018-0119
Published: 13 November 2018
Journal Article
A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer
Naoya Hashimoto and others
The Oncologist, Volume 24, Issue 2, February 2019, Pages 159–e66, https://doi.org/10.1634/theoncologist.2018-0580
Published: 10 October 2018
Advertisement
Advertisement